2m 2m 2m 2m 2m 2m 2m
CONNECT BIOPHAR (CNTB)
NASDAQ
$2.14+$0.05 (+2.25%)
Price as of Jun 23, 2026 7:43 PM EDT- $110.9MMarket Cap
- 118.69%1-Year Change
- BiotechnologyIndustry
CONNECT BIOPHAR (CNTB)
$2.14+$0.05 (+2.25%)
CNTB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.09 | ||
Change | +$0.10 (+5.03%) | ||
Open | $1.94 | ||
High | $2.12 | ||
Low | $1.92 | ||
Previous Close | $1.99 | ||
Volume | 312,540 | ||
30-Day Average Volume | 326,236 | ||
1-Week Change | 5.03% | ||
1-Month Change | -11.06% | ||
1-Year Change | 118.69% | ||
3-Year Change | 71.31% | ||
5-Year Change | -88.69% | ||
Fundamentals | |||
Shares Outstanding | 55.7M | ||
Total Assets | $60.1M | ||
Market Cap | $110.9M | ||
Enterprise Value | $64.9M | ||
Period: QTR TTM FY | |||
Revenue | $169,000.00 | ||
Net Income | -$19.4M | ||
Free Cash Flow | -$16.0M | ||
EBIT | -$19.4M | ||
EBITDA | -$19.2M | ||
Net Working Capital | $38.0M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 384 | ||
P/B | 3 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue